Atherogenics is a biopharmaceutical company based in Atlanta, GA, specializing in the research and development of innovative therapies for cardiovascular diseases.
The company focuses on advancing novel treatment options to address the unmet medical needs of patients with atherosclerosis and related conditions.
Generated from their business information